89 related articles for article (PubMed ID: 11519039)
1. Induction of urokinase-type plasminogen activator by the anthracycline antibiotic in human RC-K8 lymphoma and H69 lung-carcinoma cells.
Kiguchi T; Niiya K; Shibakura M; Miyazono T; Shinagawa K; Ishimaru F; Kiura K; Ikeda K; Nakata Y; Harada M
Int J Cancer; 2001 Sep; 93(6):792-7. PubMed ID: 11519039
[TBL] [Abstract][Full Text] [Related]
2. Induction of TNF-alpha, uPA, IL-8 and MCP-1 by doxorubicin in human lung carcinoma cells.
Niiya M; Niiya K; Kiguchi T; Shibakura M; Asaumi N; Shinagawa K; Ishimaru F; Kiura K; Ikeda K; Ueoka H; Tanimoto M
Cancer Chemother Pharmacol; 2003 Nov; 52(5):391-8. PubMed ID: 12908082
[TBL] [Abstract][Full Text] [Related]
3. Involvement of ERK1/2 and p38 MAP kinase in doxorubicin-induced uPA expression in human RC-K8 lymphoma and NCI-H69 small cell lung carcinoma cells.
Niiya M; Niiya K; Shibakura M; Asaumi N; Yoshida C; Shinagawa K; Teshima T; Ishimaru F; Ikeda K; Tanimoto M
Oncology; 2004; 67(3-4):310-9. PubMed ID: 15557793
[TBL] [Abstract][Full Text] [Related]
4. Camptothecin induces urokinase-type plasminogen activator gene-expression in human RC-K8 malignant lymphoma and H69 small cell lung cancer cells.
Shibakura M; Niiya K; Kiguchi T; Nakata Y; Tanimoto M
Acta Med Okayama; 2002 Oct; 56(5):223-7. PubMed ID: 12530505
[TBL] [Abstract][Full Text] [Related]
5. Induction of IL-8 and monoclyte chemoattractant protein-1 by doxorubicin in human small cell lung carcinoma cells.
Shibakura M; Niiya K; Kiguchi T; Kitajima I; Niiya M; Asaumi N; Huh NH; Nakata Y; Harada M; Tanimoto M
Int J Cancer; 2003 Jan; 103(3):380-6. PubMed ID: 12471621
[TBL] [Abstract][Full Text] [Related]
6. Amurubicinol-induced eotaxin-3 expression in human NCI-H69 small cell lung carcinoma cells.
Niiya M; Niiya K; Shibakura M; Asaumi N; Yoshida C; Tanimoto M
Oncol Rep; 2006 Mar; 15(3):571-6. PubMed ID: 16465414
[TBL] [Abstract][Full Text] [Related]
7. Modulation of urokinase-type plasminogen activator gene expression by inflammatory cytokines in human pre-B lymphoma cell line RC-K8.
Niiya K; Shinbo M; Ozawa T; Hayakawa Y; Sakuragawa N
Thromb Haemost; 1995 Dec; 74(6):1511-5. PubMed ID: 8772229
[TBL] [Abstract][Full Text] [Related]
8. Cytoplasmic-nuclear shuttling of the urokinase mRNA binding protein regulates message stability.
Shetty S
Mol Cell Biochem; 2002 Aug; 237(1-2):55-67. PubMed ID: 12236587
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of a synthetic prostacyclin analogue, beraprost, on urokinase-type plasminogen activator expression in RC-K8 human lymphoma cells.
Nomura N; Niiya K; Shinbo M; Ozawa T; Hayakawa Y; Higashiyama K; Fujimaki M; Sakuragawa N
Thromb Haemost; 1996 Jun; 75(6):928-32. PubMed ID: 8822588
[TBL] [Abstract][Full Text] [Related]
10. Protein kinase activity-dependent inhibition of urokinase-type plasminogen activator gene transcription by cyclic AMP in human pre-B lymphoma cell line RC-K8.
Shinbo M; Niiya K; al-Mokdad M; Hayakawa Y; Hiraga K; Fujimaki M; Sakuragawa N
Biochim Biophys Acta; 1995 Sep; 1268(3):293-9. PubMed ID: 7548228
[TBL] [Abstract][Full Text] [Related]
11. Expression of urokinase-type plasminogen activator, its receptor and type-1 plasminogen activator inhibitor is differently regulated by inhibitors of protein synthesis in human cancer cell lines.
Lund LR
FEBS Lett; 1996 Apr; 383(3):139-44. PubMed ID: 8925884
[TBL] [Abstract][Full Text] [Related]
12. Protein synthesis and urokinase mRNA metabolism.
Shetty S
Mol Cell Biochem; 2005 Mar; 271(1-2):13-22. PubMed ID: 15881651
[TBL] [Abstract][Full Text] [Related]
13. Platelet-activating factor enhances urokinase-type plasminogen activator gene expression in corneal epithelium.
Tao Y; Bazan HE; Bazan NG
Invest Ophthalmol Vis Sci; 1996 Sep; 37(10):2037-46. PubMed ID: 8814143
[TBL] [Abstract][Full Text] [Related]
14. Urokinase-mediated posttranscriptional regulation of urokinase-receptor expression in non small cell lung carcinoma.
Montuori N; Mattiello A; Mancini A; Taglialatela P; Caputi M; Rossi G; Ragno P
Int J Cancer; 2003 Jun; 105(3):353-60. PubMed ID: 12704669
[TBL] [Abstract][Full Text] [Related]
15. Induction of urokinase-type plasminogen activator by lipopolysaccharide in PC-3 human prostatic cancer cells.
Ohta S; Niiya K; Sakuragawa N; Fuse H
Thromb Res; 2000 Mar; 97(5):343-7. PubMed ID: 10709910
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor beta inhibits plasminogen activator (PA) activity and stimulates production of urokinase-type PA, PA inhibitor-1 mRNA, and protein in rat osteoblast-like cells.
Allan EH; Zeheb R; Gelehrter TD; Heaton JH; Fukumoto S; Yee JA; Martin TJ
J Cell Physiol; 1991 Oct; 149(1):34-43. PubMed ID: 1834680
[TBL] [Abstract][Full Text] [Related]
17. Effects of N-(4-hydroxyphenyl) retinamide on urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in prostate adenocarcinoma cell lines.
Tanabe T
Hiroshima J Med Sci; 2000 Mar; 49(1):67-72. PubMed ID: 10824459
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of urokinase secretion from a human lymphoma cell line RC-K8 by dexamethasone without inducing plasminogen activator inhibitors.
Niiya K; Nsimba M; Hayashi T; Sakuragawa N
Thromb Res; 1992 Feb; 65(3):311-21. PubMed ID: 1631798
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase C mediates up-regulation of urokinase and its receptor in the migrating keratinocytes of wounded cultures, but urokinase is not required for movement across a substratum in vitro.
Ando Y; Jensen PJ
J Cell Physiol; 1996 Jun; 167(3):500-11. PubMed ID: 8655604
[TBL] [Abstract][Full Text] [Related]
20. Amiloride modulates urokinase gene expression at both transcription and post-transcription levels in human colon cancer cells.
Wang Y; Dang J; Liang X; Doe WF
Clin Exp Metastasis; 1995 May; 13(3):196-202. PubMed ID: 7750207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
